Login

TI Ref No :	522073817
Description :	Medicines With The Active Substance Rivaroxaban (atc: B01af01 - In All Active Strengths Except 2.5 Mg Per Divided Oral Form)
Date :	2025-08-27
Deadline :	2026-02-22
Document Type :	Tenders